200 related articles for article (PubMed ID: 33414400)
21. Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib.
Aypar E; İzzettin FV; Akı ŞZ; Sancar M; Yeğin ZA; Türköz-Sucak G
J Oncol Pharm Pract; 2018 Jun; 24(4):281-289. PubMed ID: 29284356
[TBL] [Abstract][Full Text] [Related]
22. High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma.
Koh LP; Linn YC; Teoh G; Goh YT; Tan PH
Ann Acad Med Singap; 2002 Nov; 31(6):731-7. PubMed ID: 12520826
[TBL] [Abstract][Full Text] [Related]
23. Second primary malignancy after multiple myeloma-population trends and cause-specific mortality.
Costa LJ; Godby KN; Chhabra S; Cornell RF; Hari P; Bhatia S
Br J Haematol; 2018 Aug; 182(4):513-520. PubMed ID: 29974936
[TBL] [Abstract][Full Text] [Related]
24. Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men.
Anderson LJ; Migula D; Abay R; Crabtree S; Graf SA; Matsumoto AM; Chauncey TR; Garcia JM
Andrology; 2022 Feb; 10(2):291-302. PubMed ID: 34624176
[TBL] [Abstract][Full Text] [Related]
25. Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
Toro JJ; Gushiken FC; Schneider D; Lee S; Haile DJ; Freytes CO
Support Care Cancer; 2016 Aug; 24(8):3411-5. PubMed ID: 26984247
[TBL] [Abstract][Full Text] [Related]
26. Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan.
Liu Y; Hou HA; Qiu H; Tang CH
Sci Rep; 2020 Sep; 10(1):14393. PubMed ID: 32873831
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
[TBL] [Abstract][Full Text] [Related]
28. Increasing therapy-related myeloid neoplasms in multiple myeloma.
Fernández-Caballero M; Salmerón D; Dolores Chirlaque M; Chen-Liang TH; Hurtado AM; García Malo MD; Ortuño FJ; Roldán V; Vicente V; Jerez A; De Arriba F
Eur J Clin Invest; 2019 Feb; 49(2):e13050. PubMed ID: 30422316
[TBL] [Abstract][Full Text] [Related]
29. Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis.
Alping P; Burman J; Lycke J; Frisell T; Piehl F
Neurology; 2021 Mar; 96(11):e1574-e1584. PubMed ID: 33514645
[TBL] [Abstract][Full Text] [Related]
30. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Varma A; Biritxinaga L; Saliba RM; Stich M; Jauch SF; Afrough A; Honhar M; Popat UR; Shafi MA; Shah N; Bashir Q; Dinh Y; Hosing C; Champlin RE; Qazilbash MH
Biol Blood Marrow Transplant; 2017 Apr; 23(4):581-587. PubMed ID: 28063964
[TBL] [Abstract][Full Text] [Related]
31. Highly proliferative and functional PD-1
Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
[TBL] [Abstract][Full Text] [Related]
32. Second primary malignancies and myeloma therapy: fad or fact?
Usmani SZ
Oncotarget; 2012 Sep; 3(9):915-6. PubMed ID: 22989934
[TBL] [Abstract][Full Text] [Related]
33. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation.
Aladağ Karakulak E; Demiroğlu H; Büyükaşik Y; Turgut M; Aksu S; Sayinalp N; Haznedaroğlu IC; Özcebe OI; Göker H
Turk J Med Sci; 2020 Dec; 50(8):1851-1856. PubMed ID: 32512672
[TBL] [Abstract][Full Text] [Related]
34. A Mixed-Methods Study of Stem Cell Transplantation Utilization for Newly Diagnosed Multiple Myeloma.
Fiala MA; Vij R; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e521-e525. PubMed ID: 31320252
[TBL] [Abstract][Full Text] [Related]
35. Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.
Engelhardt M; Ihorst G; Landgren O; Pantic M; Reinhardt H; Waldschmidt J; May AM; Schumacher M; Kleber M; Wäsch R
Haematologica; 2015 Oct; 100(10):1340-9. PubMed ID: 26160877
[TBL] [Abstract][Full Text] [Related]
36. Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysis.
Giri S; Barth P; Costa LJ; Olszewski AJ
J Geriatr Oncol; 2021 Mar; 12(2):256-261. PubMed ID: 32684352
[TBL] [Abstract][Full Text] [Related]
37. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
38. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
[TBL] [Abstract][Full Text] [Related]
39. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
40. Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase.
Awada H; Hajj Ali A; Anwer F; Shahzad R; Mazzoni S; Williams L; Chaulagain C; Hamilton B; Sauter C; Khouri J
Clin Appl Thromb Hemost; 2023; 29():10760296231177678. PubMed ID: 37277999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
